NCT02538341 2021-11-23Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)University of Alabama at BirminghamPhase 2 Completed617 enrolled 17 charts
NCT01767467 2018-06-06Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood CancersGlaxoSmithKlinePhase 3 Completed568 enrolled 26 charts